AwardedCzechiaGoodsCZK 77,020,653
Léčivý přípravek LUTATHERA a PLUVICTO
- Published
- Published 3 September 2025
Overview
Předmětem plnění VZ jsou dodávky léčivého přípravku LUTATHERA a PLUVICTO. Jedná se o léčivé přípravky jejichž jediným držitelem registrace (MAH) je společnost Novartis Europharm Limited, Dublin, jejichž distribuci pro Českou republiku zajišťuje Novartis, s.r.o., Na Pankráci 1724/129, 140 00 Praha 4, Nusle, IČ: 64575977
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 77,020,653
- Procedure
- Direct
- Published
- 3 September 2025
Radio-isotopes
Award outcome
- Awarded value
- CZK 75,170,718
- Award date
- 31 July 2025
- Contract period
- 8 August 2025 → 18 July 2029
- Novartis, s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 September 2025
Contracting authority
Fakultní nemocnice Ostrava
Procuring entityOstrava, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.